Abogenbio
Latest round
- Series C
Last raised
- Nov 2021
Total raised
- $1.1B
Investors
- 40
About Abogenbio
Established in 2019 and based in Suzhou, China, Abogenbio operates as a nucleic acid drug developer that provides drug treatment services. The company has a branch and office in Shanghai and Beijing. In June 2020, the novel coronavirus mRNA vaccine (ARCoV) jointly developed by Abogenbio, the Institute of Military Medicine of the Academy of Military Sciences and Yunnan Watson Biotechnology, officially passed the drug clinical trial approval of the National Medical Products Administration. The company uses mRNA technology and LNP platform to develop infectious disease control, tumor immunization, tumor vaccines and protein replacement therapy. Its pipeline product includes ARCoV.
Who invested in Abogenbio
40 investors across 5 rounds
See all investors in Abogenbio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Abogenbio
Who invested in Abogenbio?
Abogenbio has 40 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Abogenbio raised?
Abogenbio has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Abogenbio last raise money?
Abogenbio's most recent round on record is a Series C, in Nov 2021.
What does Abogenbio do?
Established in 2019 and based in Suzhou, China, Abogenbio operates as a nucleic acid drug developer that provides drug treatment services.
Where is Abogenbio headquartered?
Abogenbio is headquartered in Suzhou, China.
Which VCs invest in companies like Abogenbio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Abogenbio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Abogenbio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.